MedTrace Logo

Basivertebral Nerve Ablation With the Intracept Procedure

NCT05692440 · Status: ENROLLING_BY_INVITATION · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2024-03-21

No results posted yet for this study

Summary

This is an independent prospective, noninterventional, single arm post market data collection of the patient-reported effectiveness, ongoing safety, and satisfaction outcomes for patients treated with intraosseous basivertebral nerve ablation using the Intracept Procedure at a single study site.

Conditions

  • Low Back Pain

Interventions

DEVICE

Intracept Procedure

Intraosseous radiofrequency ablation of the basivertebral nerve

Sponsors & Collaborators

  • Neuro Spine and Pain Center of Key West

    lead OTHER

Principal Investigators

  • William Schnapp, PhD · Owner

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
84 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-03
Primary Completion
2026-01-01
Completion
2026-06-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05692440 on ClinicalTrials.gov